Thermo Fisher Scientific Inc 8-K, filed Nov 20, 2020
Thermo Fisher Scientific Inc. (TMO)
8-K
2020-11-20
For: 2020-11-20
View Original
Added on
April 07, 2026
About this 8-K
Thermo Fisher Scientific Inc filed this 8-K on November 20, 2020.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 20, 2020
(Exact name of Registrant as specified in its Charter)
| (State of incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||||||||
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (781 ) 622-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. ☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
THERMO FISHER SCIENTIFIC INC.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 20, 2020, the Board of Directors of Thermo Fisher Scientific Inc. (the “Company”), elected R. Alexandra Keith as a director of the Company for a term expiring at the 2021 annual meeting. Ms. Keith is the Chief Executive Officer of Procter & Gamble’s (“P&G”) global Beauty business, based in Geneva, Switzerland, and sits on P&G's Global Leadership Council. In her current role, she oversees a $13 billion business with 10,000 employees around the world. Alex has spent her entire 30-year career at P&G in a variety of roles including manufacturing, logistics, communications and product innovation.
In connection with her service as a director, Ms. Keith will be entitled to receive the Company’s previously disclosed standard agreements and arrangements for non-employee directors as described in Exhibit 10.4 to the Company's annual report on Form 10-K for the year ended December 31, 2019, which was filed with the SEC on February 26, 2020 (File No. 001-08002), and will enter into the Company’s standard form of indemnification agreement, which was filed as Exhibit 10.2 to the Company’s Registration Statement on Form S-4 (Reg. No. 333-90661).
2
THERMO FISHER SCIENTIFIC INC.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| THERMO FISHER SCIENTIFIC INC. | |||||||||||
| Date: | November 20, 2020 | By: | /s/ Michael A. Boxer | ||||||||
| Michael A. Boxer | |||||||||||
| Senior Vice President and General Counsel | |||||||||||
3